bluebird bio extends selloff as BofA and J.P. Morgan cut after Q3 results
(NASDAQ:BLUE) traded lower for the fourth straight session as Bank of America and J.P. Morgan downgraded the gene therapy developer after its Q3 2024 results fell short of expectations for ...
Main Street Investors Are Piling Into the Trump Trade. Watch Out.
The share of individual investors who say they are bullish is way above average, according to the American Association of ...